Agenda for Day 1 – Tuesday, March 23, 2027Tuesday, 23 March 2027 - EST/EDT (Eastern Daylight, GMT-4)

Katy Sullivan’s story is one of challenging assumptions, redefining possibility, and refusing to let the world put her in a box. Born without legs, Katy was told by a doctor at birth that “the world doesn’t need more runners.” Years later, she became a Paralympic sprinter, the first female amputee to perform on Broadway, and the first amputee nominated for a Tony Award.

Through her personal journey from hiding what made her different to embracing it, Katy explores the power of identity, mindset, resilience, and choosing who gets to define your story. Her keynote challenges audiences to stop limiting themselves based on expectations, whether their own or someone else’s, and to take ownership of what comes next.

Recently, Americans have seen some of the most patient-friendly laws and the nation's safety net significantly altered, creating new challenges and a changing landscape for all patient stakeholders. 
 
The passage of the One Big Beautiful Bill Act, the non-renewal of Affordable Care Act subsidies, and the rising rate of uninsured patients have the patient community and manufacturers re-examining resources required for patient assistance programs, safety net and free drug programs, foundational giving, and other non-medical support needs. 
 
This conversation convenes diverse voices from across the healthcare continuum to discuss what is changing, what is working, and where critical gaps remain. Through a combination of stakeholder insights and audience engagement, participants will examine the key trends influencing access, affordability, navigation, and patient support while exploring practical opportunities for collaboration and action. 

Participants will leave with: 

• A clearer understanding of the trends shaping patient access in 2027 and beyond, including the challenges and opportunities emerging across the healthcare ecosystem. 

• Insights from multiple stakeholder perspectives, helping attendees better understand how patients, providers, specialty pharmacies, advocacy organizations, and industry partners experience and address access barriers differently. 

• Practical ideas for collaboration, with opportunities to identify strategies, partnerships, and solutions that can improve the patient experience and strengthen access outcomes. 

This fireside chat explores how disrupting the traditional pharmaceutical supply chain with a transparent, direct-to-patient channel can eliminate complex hub friction, lower manufacturer administrative burdens and secure immediate, affordable therapy access for patients.

As multiple healthcare policies converge in January 2027, patient support programs face unprecedented challenges and opportunities. This critical session equips stakeholders with the strategic insights and practical tools needed to navigate this complex regulatory landscape and maintain seamless patient access.

• Identify and prioritize the legislative and regulatory changes poised to reshape patient support programs and access initiatives in 2027, with actionable intelligence on implementation timelines and compliance requirements

• Understand how government agencies, industry leaders and patient advocacy organizations interpret and respond to policy changes differently, enabling you to anticipate friction points and identify collaboration opportunities

• Analyze the immediate operational, financial and patient-facing implications of January 2027 policy implementations on patient support program infrastructure, workflows and resource allocation.

• Leverage Political Intelligence and gain strategic insights into how midterm election outcomes are shaping the policy environment, with trend analysis that extends into 2028 and beyond, helping you position programs for long-term sustainability

• Discover how leading manufacturers are deploying AI and automation to reduce intake-to-fill timelines

• Understand the benefits of shifting away from siloed call centers to integrated, real-time data ecosystems that seamlessly connect specialty pharmacies, distributors and providers

• Learn how to structure financial assistance, prioritize provider workflow support and determine when a traditional hub is (or isn't) necessary for your product.

• Examine emerging technologies reshaping access delivery, such as telehealth integration

• Walk away with a decision framework for evaluating your hub's evolution: assess where technology should replace administrative burden, how to build comprehensive support within regulatory boundaries and what "hub" truly means in 2026 as the definition continues to shift from a one-stop-shop to a strategic partner ecosystem

• Debate the ROI of AI agents and bot-driven patient interactions – does automation truly decrease pharma spend and accelerate workflows, or are we overpromising on efficiency while underdelivering on patient preference?

• Explore how AI-generated insights translate into actionable day-to-day operations and whether manufacturers can actually learn smarter from these predictive analytics

• Tackle the organizational challenge of making your team comfortable in adopting AI tools and determine where the line should be drawn between automation and preserving the human touch

• Create a balanced framework for AI deployment in your hub: understand which tasks are ripe for automation and where human case managers remain non-negotiable

• Understand how fragmented data across hubs, specialty pharmacies, field teams and commercial partners limits your ability to see the full patient journey and make timely, informed decisions

• Learn how to build a scalable data infrastructure that consolidates disparate sources, establishes governance standards and ensures data quality without creating bottlenecks or silos

• Explore strategies for enabling cross-functional access to patient journey data while maintaining security, compliance and role-based permissions that protect sensitive information

• Discover how advanced analytics, segmentation and real-time dashboards can turn raw data into actionable insights that drive operational efficiency, identify trends and support strategic planning

• Discover how to integrate clinical nursing services into patient support programs to differentiate complex therapies in increasingly competitive markets

• Understand the barriers that traditional hub models cannot address, including therapy administration complexity, adherence challenges and fragmented care coordination, and recognize when clinical support becomes a strategic necessity rather than a nice-to-have

• Learn how to structure in-home nursing and clinical services alongside existing hub infrastructure, including partnership models, workflow integration and coordination strategies that accelerate therapy start and improve persistence

• Examine the operational and commercial impact of clinical care models, including real-world examples of how manufacturers are removing barriers to therapy access by delivering nursing support directly in the patient's home

• Walk away with a decision framework for evaluating whether your therapy and patient population would benefit from clinical support integration

• Examine how patient consent has evolved from a compliance checkbox to a strategic enabler, and explore emerging models that are expanding what's possible in terms of data sharing, HCP collaboration and service delivery

• Learn how to compliantly maximize the scope and utility of patient consent by understanding legal boundaries, determining who can access what data and identifying opportunities to broaden consent without crossing regulatory lines

• Explore how unified consent infrastructure allows you to track patient adherence, identify drop-off points in real time and intervene proactively to keep patients on therapy and improve long-term outcomes

• Discover how to build a consent framework that enables your hub, partners and field teams to know which patients have opted in, what they've consented to and how to act on that information in a timely fashion